Recent Updates
Recently added Catalysts
RMD Positive Sentiment Score: 70/100

ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Key Takeaway: ResMed has announced the participation of its executives, Mick Farrell and Dr. Carlos Nunez, at the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2025. The event will include a live audio-only webcast, with a replay available for 30 days post-event. This participation highlights ResMed's commitment to innovation in healthcare, focusing on solutions for chronic diseases like sleep apnea and COPD. The company emphasizes its role in empowering healthier lifestyles through advanced digital health technologies and cloud-connected devices.

Market Sentiment Analysis

POSITIVE FACTORS

  • ResMed is participating in the prestigious J.P. Morgan Healthcare Conference.
  • The company is led by experienced executives, showcasing leadership.
  • ResMed's innovative solutions aim to improve health outcomes and reduce healthcare costs.
  • The event offers a platform to share advancements in healthcare technology.

Full Press Release Details

SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, beginning at approximately 3:00 p.m. (Pacific Standard Time) in San Francisco, CA.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
For investors For media
+1 858.836.5000 +1 619.510.1281
investorrelations@resmed.com news@resmed.com

Frequently Asked Questions

When will ResMed speak at the J.P. Morgan Healthcare Conference?

ResMed will present on January 13, 2025, at 3:00 p.m. PST.

Where can I access the live webcast of ResMed's presentation?

The live webcast can be accessed at https://investor.resmed.com.

How long will the webcast replay be available?

The replay will be available for 30 days after the live event.

What technologies does ResMed offer?

ResMed provides digital health technologies for sleep apnea and COPD care.

In how many countries does ResMed operate?

ResMed operates in over 140 countries worldwide.

Last updated: Jan 6, 2025